Arvinas, Inc(ARVN)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$7.67
52-Week Range
$6.05 – $14.51
YTD
-33.13%
IV Rank (30D)
61.33
Straddle Price
$1.12
P/C Vol Ratio
0.14
Market Cap
$0.5B
Fair Value
+18.7% vs price
Confidence: 39% Alpha Score: 0.30

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.43%
Beta vs SPY1.25
Cost of Equity (CAPM)11.30% (VRP-adj)
WACC10.25%
Volatility Risk Premium+122.8pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)-10.0%
DCF Horizon10 years explicit + fade
Free Cash Flow (TTM)$-0.3B
Return on Equity (TTM)-57.2%
Book / Price71.8% — banking bias active (P/B is primary)
Gross Margin (TTM)100.0%
FCF Margin (TTM)-287.4%
Debt / Equity0.00
Quality Score2/6 — normal (10y DCF)
SMA 50$9.31 (Market Anchor value)
SMA 20 / Bollinger Mid$7.97
Bollinger Width / SMA20459.2% (drives anchor stability)
Net Debt$-0.1B
Market Cap$1B
Peers used for multiples: ABT, PFE, REGN, TEVA (SIC-code peers; ETF co-membership was sector-incoherent)
Blended Fair Value
$9.11
Current Price
$7.67
Deviation
+18.7%
Forward-Return Rank LONG gates ✓
?
Horizon Expected α z Pred Blended z Rank % Active?
21d -0.4% +0.54 +0.41 50.2%
42d -1.2% +0.41 +0.35 45.1%
63d -2.0% +0.24 +0.26 38.6%
Expected α = forward-return point estimate vs SPY (e.g., +7.5% means the predictor expects this stock to outperform SPY by 7.5% over that horizon). For SHORT direction the model uses a different ranking metric (conviction-weighted deviation, not the LGBM prediction); Expected α is shown for reference. flags rows where Expected α disagrees with the FV direction — two independent signals are in conflict; conviction is low even if rank looks extreme.
Forward-Return Rank. A proprietary ensemble of a machine-learning forward-return model and a conviction-weighted fundamental score, ranked cross-sectionally each day across the S&P 500 (and broader universes on the screener). Each stock is scored at three horizons (21/42/63 trading days). "Active" = top/bottom 5% AND all risk filters pass. Backtested mean alpha vs SPY on active picks: 21d LONG +13.4%, 63d +34.9% (S&P 500, walk-forward). Past performance is not indicative of future results.
Value vs momentum conflict ⚠. The "FV direction" (long/short) comes from the fundamentals-based engine — price vs intrinsic value. The "Expected α" comes from a separate machine-learning predictor trained on ~12 features (sector, options-implied move, beta, institutional flow, etc.). Sometimes the two disagree: a stock is overvalued by fundamentals but the predictor expects it to keep outperforming (sector or momentum tailwinds). When all 3 horizons disagree, treat the direction signal as low-conviction — neither model is strongly recommending a position.
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 22.0× · 4 peers
Peer EV/EBITDA n/a 0% median 12.7× · 4 peers
Peer P/B $13.73 17% median 2.5× · 4 peers
Peer P/S $3.66 17% median 2.9× · 4 peers
Market Anchor (SMA50) $9.31 66% stability 77% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-06-19 · updated 2026-06-19 21:00:06.101000
Info
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNAS
Market Cap
$0.5B

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV…

Chart
Seasonality
MonthAvg ReturnYears of Data
Jan -4.18% 6
Feb -2.87% 6
Mar -15.53% 6
Apr +0.29% 6
May -4.25% 6
Jun -2.99% 6
Jul +10.99% 5
Aug -4.37% 5
Sep -5.30% 5
Oct +6.17% 5
Nov +5.23% 5
Dec +10.16% 5
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $7.97
SMA 50: $9.31
SMA 200: $10.66
Current: $7.67
EMA 12: $7.66
EMA 26: $8.22
MACD: -0.5645 | Signal: 0.0793
BEARISH
ADX (14): 33.74
TREND
+DI: 19.65
−DI: 25.40
Momentum Oscillators
RSI (14): 38.85
NEUTRAL
Stoch %K: 29.37
Stoch %D: 26.76
Williams %R: -66.67
Volume & Volatility
BB Upper: $9.43
BB Lower: $6.51
NEUTRAL
OBV: 21,913,392
Vol SMA 20: 747,138
Vol ROC: 66.50%
ATR: $0.45
True Range: $0.50
HV 20: 48.8%
HV 30: 50.3%
HV 60: 50.8%

Data Summary
Data Points: 500
Last Updated: 2026-06-18T21:15:16.077000
Date Range: 2024-06-21T00:00:00 – 2026-06-18T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Earnings History
6 of 8 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-07-30 Pre-Market 18.90% 2.48% 0.13x Within
2024-10-30 Pre-Market 14.89% 4.19% 0.28x Within
2025-02-11 Pre-Market 30.00% 6.95% 0.23x Within
2025-05-01 Pre-Market 12.45% 24.85% 2.00x Exceeded
2025-08-06 Pre-Market 11.17% 13.93% 1.25x Exceeded
2025-11-05 Pre-Market 19.92% 0.31% 0.02x Within
2026-02-24 Pre-Market 18.32% 0.56% 0.03x Within
2026-05-12 Pre-Market 10.09% 0.93% 0.09x Within
Options Activity
IV Rank (30D)
61.33
IV Rank (7D)
100
Avg IV
173.1%
Straddle (30D)
$1.12
Straddle (7D)
$0.60
P/C Volume
0.14
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
pts EXTREME
ATM — / Wing —
30 DTE / 10d
pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
1.07
Correlation (SPY)
23.5%
0.06
Ann. Volatility
56.3%
SPY Volatility
12.4%

Above average volatility - stock moves with market amplification

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31
Diluted shares outstanding: 70,275,000 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

207 filers56,137,147 shares$578.19M value79.88% of float
# Filer Shares Value % of Total % of Float Period
1 VANGUARD GROUP INC Custodian 7,229,603 $85.74M 14.83% 10.29% 2025-12-31
2 BlackRock, Inc. Custodian 6,797,584 $72.05M 12.46% 9.67% 2026-03-31
3 D. E. Shaw & Co., Inc. Custodian 3,638,567 $38.57M 6.67% 5.18% 2026-03-31
4 PFIZER INC 3,457,815 $34.92M 6.04% 4.92% 2026-03-31
5 TCG Crossover Management, LLC 2,387,461 $25.31M 4.38% 3.40% 2026-03-31
6 ARMISTICE CAPITAL, LLC 1,978,000 $20.97M 3.63% 2.81% 2026-03-31
7 TWO SIGMA INVESTMENTS, LP 1,832,114 $19.42M 3.36% 2.61% 2026-03-31
8 STATE STREET CORP 1,828,472 $19.38M 3.35% 2.60% 2026-03-31
9 GEODE CAPITAL MANAGEMENT, LLC Custodian 1,557,107 $16.51M 2.86% 2.22% 2026-03-31
10 JACOBS LEVY EQUITY MANAGEMENT, INC 1,441,521 $15.28M 2.64% 2.05% 2026-03-31
11 New Leaf Venture Partners, L.L.C. 1,585,721 $13.51M 2.34% 2.26% 2025-09-30
12 Qube Research & Technologies Ltd 1,201,635 $12.74M 2.20% 1.71% 2026-03-31
13 CITADEL ADVISORS LLC Custodian 1,180,988 $12.52M 2.17% 1.68% 2026-03-31
14 FEDERATED HERMES, INC. 1,140,715 $12.09M 2.09% 1.62% 2026-03-31
15 MORGAN STANLEY Custodian 810,072 $9.61M 1.66% 1.15% 2025-12-31
16 Vestal Point Capital, LP 905,465 $9.60M 1.66% 1.29% 2026-03-31
17 GOLDMAN SACHS GROUP INC Custodian 756,875 $8.02M 1.39% 1.08% 2026-03-31
18 MILLENNIUM MANAGEMENT LLC Custodian 576,352 $6.11M 1.06% 0.82% 2026-03-31
19 KENNEDY CAPITAL MANAGEMENT LLC 552,641 $5.86M 1.01% 0.79% 2026-03-31
20 Nextech Invest, Ltd. 539,394 $5.72M 0.99% 0.77% 2026-03-31
21 TANG CAPITAL MANAGEMENT LLC 538,658 $5.71M 0.99% 0.77% 2026-03-31
22 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 525,174 $5.57M 0.96% 0.75% 2026-03-31
23 NORTHERN TRUST CORP Custodian 520,955 $5.52M 0.96% 0.74% 2026-03-31
24 DIMENSIONAL FUND ADVISORS LP Custodian 485,764 $5.15M 0.89% 0.69% 2026-03-31
25 NORDEA INVESTMENT MANAGEMENT AB 474,503 $5.05M 0.87% 0.68% 2026-03-31
7 filers$3.08M notional
# Filer Notional Value % of Total Period
1 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $845.88K 27.48% 2026-03-31
2 WOLVERINE TRADING, LLC Custodian $645.72K 20.98% 2025-09-30
3 JANE STREET GROUP, LLC Custodian $636.00K 20.66% 2026-03-31
4 CITADEL ADVISORS LLC Custodian $372.06K 12.09% 2026-03-31
5 SIMPLEX TRADING, LLC Custodian $366.76K 11.91% 2026-03-31
6 IMC-Chicago, LLC Custodian $203.52K 6.61% 2026-03-31
7 GROUP ONE TRADING LLC Custodian $8.48K 0.28% 2026-03-31
6 filers$1.08M notional
# Filer Notional Value % of Total Period
1 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $319.06K 29.60% 2026-03-31
2 SIMPLEX TRADING, LLC Custodian $227.90K 21.15% 2026-03-31
3 WOLVERINE TRADING, LLC Custodian $210.69K 19.55% 2025-09-30
4 JANE STREET GROUP, LLC Custodian $193.98K 18.00% 2026-03-31
5 CITADEL ADVISORS LLC Custodian $120.84K 11.21% 2026-03-31
6 GROUP ONE TRADING LLC Custodian $5.30K 0.49% 2026-03-31
Insider Activity
Latest: 2026-05-22
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-05-22 Randy Teel President and CEO Sell (S) −2,209 $9.04 -$20.0K EDGAR
2026-05-13 Randy Teel President and CEO Sell (S) −9,657 $9.94 -$96.0K EDGAR
2026-05-13 David K Loomis VP, Chief Accounting Officer Sell (S) −1,919 $9.94 -$19.1K EDGAR
2026-05-13 Noah Berkowitz Chief Medical Officer Sell (S) −11,108 $9.94 -$110.4K EDGAR
2026-05-13 Angela M Cacace Chief Scientific Officer Sell (S) −9,657 $9.94 -$96.0K EDGAR
2026-05-13 Andrew Saik Chief Financial Officer Sell (S) −11,139 $9.94 -$110.7K EDGAR
2026-03-19 Noah Berkowitz Chief Medical Officer Sell (S) −6,435 $11.10 -$71.4K EDGAR
2026-03-12 Randy Teel President and CEO Award (A) +147,179 EDGAR
2026-03-09 Briggs Morrison Director Buy (P) +20,000 $13.40 $268.1K EDGAR
2026-03-02 Randy Teel President and CEO Award (A) +147,791 EDGAR
2026-03-02 Angela M Cacace Chief Scientific Officer Award (A) +45,000 EDGAR
2026-03-02 Noah Berkowitz Chief Medical Officer Award (A) +45,000 EDGAR
2026-03-02 Andrew Saik Chief Financial Officer Award (A) +45,000 EDGAR
2026-03-02 John G Houston Director Sell (S) −35,297 $13.21 -$466.2K EDGAR
2026-03-02 David K Loomis VP, Chief Accounting Officer Award (A) +12,420 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
32 insiders · @ $7.67
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 SCOTT M ROCKLAGE 10%+ Owner 4,512,136 $34.61M -$30.68M 1 2019-04-01
2 Canaan Partners IX LLC 10%+ Owner 3,989,554 $30.60M $0 2 2020-07-21
3 Andrew J. Schwab 10%+ Owner 3,888,216 $29.82M -$106.29M 2 2019-07-01
4 Canaan IX L.P. 10%+ Owner 3,589,554 $27.53M $0 2 2020-10-15
5 RA CAPITAL MANAGEMENT, L.P. 3,138,412 $24.07M $48.00M 1 2018-10-03
6 TIMOTHY M SHANNON Director 1,772,501 $13.60M -$34.14M 13 2022-06-21
7 Jakob Loven Director 1,694,351 $13.00M $5.00M 3 2020-06-04
8 John G Houston President and CEO 1,152,792 $8.84M -$17.26M 23 2026-03-02
9 ELM STREET VENTURES L P 767,623 $5.89M $0 1 2018-10-09
10 Liam Ratcliffe Director 421,935 $3.24M -$10.41M 11 2022-06-21
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
Notice of Proposed Sale (Form 144)
Latest: 2026-06-17
Last 30d: 2 filings · $40K notice value  ·  Last 90d: 6 filings · $467K notice value · 4 unique filers · 17% under 10b5-1 plans

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.

Source & freshness: Parsed directly from EDGAR primary-doc XML. Daily refresh; new filings typically appear here the morning after they hit EDGAR.

Top 90-day filers: Randy Teel (2, $119K) · Angela Cacace (2, $119K) · Andrew Saik (1, $115K) · Noah Berkowitz (1, $114K)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-06-17 Angela Cacace Officer 2,642 $19.6K 2026-06-17 Morgan Stanley Smith Barney LLC 10b5-1 EDGAR
2026-05-20 Randy Teel Officer, Director 2,197 $20.0K 2026-05-21 Morgan Stanley Smith Barney LLC EDGAR
2026-05-08 Andrew Saik Officer 11,343 $114.7K 2026-05-11 Morgan Stanley Smith Barney LLC EDGAR
2026-05-08 Angela Cacace Officer 9,834 $99.4K 2026-05-11 Morgan Stanley Smith Barney LLC EDGAR
2026-05-08 Noah Berkowitz Officer 11,312 $114.4K 2026-05-11 Morgan Stanley Smith Barney LLC EDGAR
2026-05-08 Randy Teel Officer, Director 9,834 $99.4K 2026-05-11 Morgan Stanley Smith Barney LLC EDGAR
2026-03-17 Noah Berkowitz Officer 6,022 $72.3K 2026-03-18 Morgan Stanley Smith Barney LLC EDGAR
2026-02-27 John G. Houston former President and CEO, Director 35,297 $466.2K 2026-02-27 Morgan Stanley Smith Barney LLC EDGAR
2026-02-23 Angela Cacace Officer 3,609 $43.9K 2026-02-23 Morgan Stanley Smith Barney LLC EDGAR
2026-02-23 Randy Teel Officer, Director 4,786 $58.2K 2026-02-23 Morgan Stanley Smith Barney LLC EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/B Ratio1.3
P/S Ratio5.5
EV/EBITDA-1.6
TTM Revenue$0.1B
TTM Net Income$-0.2B
TTM EPS$-3.18
ROE-57.2%